logo
Palestinians in Gaza suffering from man-made ‘mass starvation', WHO says

Palestinians in Gaza suffering from man-made ‘mass starvation', WHO says

7NEWS24-07-2025
Twenty-one months into Israel's war in Gaza, the enclave is gripped by escalating scenes of death and hunger, with some killed while trying to reach aid, others dying of starvation and growing condemnation of Israel's conduct even among many of its closest allies.
Palestinians in Gaza are suffering from man-made 'mass starvation' due to the aid blockade on the enclave, the chief of the World Health Organization warned reporters at a briefing on Wednesday.
'Parents tell us their children cry themselves to sleep from hunger,' Director-General Tedros Adhanom Ghebreyesus said.
'Food distribution sites have become places of violence.'
The United Nations says more than a thousand people have been killed by Israeli forces while seeking food since late May, when a controversial new Israel- and US-backed aid group, the Gaza Humanitarian Foundation, began operating.
Of those, hundreds have died near GHF sites, according to the UN. The GHF was created to replace the UN's aid role in Gaza and has been widely criticised for failing to improve conditions.
All 2.1 million people in Gaza are now food insecure. On Tuesday, Gaza's health ministry said 900,000 children are going hungry, and 70,000 already show signs of malnutrition.
But how did it come to this?
A complete siege after Hamas' October 7 attack
Before the war, Gaza was already one of the most isolated and densely populated places on earth, with around two million people packed into an area of 140 square miles.
Israel has maintained tight control over the territory through a years-long land, air and sea blockade, with severe restrictions on the movement of goods and people.
More than half of its residents were food insecure and under the poverty line, according to the UN.
Between 500 and 600 truckloads of aid entered Gaza daily before the conflict. That number has since plummeted to an average of just 28 trucks per day, a group of humanitarian organisations said Wednesday. It's unclear if the figure includes trucks used in GHF's operations.
Following Hamas' October 7, 2023 attack, which left 1,200 people dead and more than 250 taken hostage, Israel ordered a 'complete siege' of Gaza, halting the supply of electricity, food, water and fuel.
A humanitarian crisis swiftly unfolded, as trapped residents faced both hunger and a devastating Israeli military campaign in response. Human rights groups have repeatedly criticised Israel's use of food as a 'weapon of war' and accused it of imposing 'collective punishment'.
Brief respite and a short-lived ceasefire
Following international pressure, the first trucks carrying aid entered Gaza in late October. A temporary ceasefire between Israel and Hamas began on November 24, 2023, slightly increasing aid flow. But the truce collapsed a week later.
Aid deliveries subsequently dwindled again, and stringent Israeli inspections further delayed shipments. Israeli authorities said screening was necessary to prevent Hamas from diverting supplies, but humanitarian officials accused Israel of deliberately throttling aid.
Further compounding the crisis was the Israeli campaign against the UN and its aid delivery system, which Israel said was ineffective and allowed aid to fall Hamas' hands. The UN denies this.
Among the agencies targeted was the UN's Relief and Works Agency for Palestine Refugees (UNRWA), which Israel accused of having staff involved in the October 7 attack.
A UN investigation found that nine of UNWRA's 13,000 Gaza-based employees 'may have' participated, and no longer worked at the agency.
In January this year, Israel banned UNRWA from operating in Gaza, cutting off viral services like food, health care and education to hundreds of thousands of people.
The breakdown of social order
As Israel's campaign levelled much of Gaza, displacing most of its residents and weakening Hamas' grip on the territory, lawlessness began to spread.
Looting became a new hurdle for UN trucks, and casualties mounted at aid delivery points. Israel has repeatedly blamed Hamas and armed gangs for the chaos.
The UN warned just weeks into the war that civil order was beginning to collapse, with desperate Palestinians taking flour and hygiene supplies from warehouses. By November 2024, the UN again raised the alarm, saying the capacity to deliver aid was 'completely gone.'
In 'one of the worst' looting incident, over 100 trucks were lost, it said. Drivers were forced to unload trucks at gunpoint, aid workers were injured, and vehicles were damaged extensively.
As Hamas' grip on Gaza waned and the territory's police force was hollowed out, gangs emerged to steal aid and resell it. Israel has also armed local militias to counter Hamas — a controversial move that opposition politicians have warned will endanger Israeli national security.
The arming of militias appears to be the closest that Israeli Prime Minister Benjamin Netanyahu has come to empowering any form of alternate rule in the strip. Since the start of the war, the Israeli leader has refused to lay out a plan for Gaza's governance once the conflict ends.
Another ceasefire collapse and a new aid system
On January 19, another temporary ceasefire was reached. Aid resumed, but remained well short of what was needed.
Israel reinstated a total blockade of Gaza on March 2 after the truce expired. Two weeks later, it resumed fighting, with officials saying the goal was to force Hamas to accept new ceasefire terms and release hostages.
By July, the World Food Programme (WFP) assessed that a quarter of Gaza's population was facing famine-like conditions.
At least 80 children have died of malnutrition since the conflict began, the Palestinian health ministry says. According to the World Health Organization (WHO), most of these occurred after the March blockade.
In May, GHF, the controversial new Israeli- and American-backed organisation, announced it would begin delivering with Israel's approval. Just days before GHF began operating, its director Jake Wood resigned, saying it was impossible to do his work 'while also strictly adhering to the humanitarian principles of humanity, neutrality, impartiality and independence'.
The foundation was created to replace the UN's role in Gaza, while complying with Israeli demands that the aid not reach Hamas. The GHF said it would coordinate with the Israeli military, but that security would be provided by private military contractors.
The UN has refused to participate, saying the GHF model violates some basic humanitarian principles. Critics have noted that there are only a small number of GHF distribution sites, in southern and central Gaza — far fewer than hundreds under the UN's previous model. This has forced massive crowds to gather at limited locations.
The GHF has defended its system, saying it is a 'secure model (that) blocks the looting'.
But soon after it began operating on May 27, the plan turned deadly as those seeking aid increasingly came under fire near GHF aid sites.
Palestinian officials and witnesses have said Israeli troops are responsible for most of the deaths. The Israeli military acknowledged firing warning shots toward crowds in some instances, but denied responsibility for other incidents.
And the deaths aren't limited to the vicinity of GHF aid sites. On Sunday, Israeli forces killed dozens waiting for aid in northern Gaza, according to the Palestinian health ministry. Israel said troops fired warning shots after sensing an 'immediate threat'
The ministry of health recorded 10 deaths due to famine and malnutrition in 24 hours from Tuesday, bringing the total of Palestinians who died of starvation to 111.
On Wednesday, 111 international humanitarian organisations called on Israel to end its blockade and agree to a ceasefire, warning that supplies in the enclave are now 'totally depleted' and that humanitarian groups are 'witnessing their own colleagues and partners waste away before their eyes'.
An Israeli official said at a press briefing on Wednesday that they expect more aid to enter the enclave in the future.
'We would like to see more and more trucks entering Gaza and distributing the aid as long as Hamas is not involved,' the official said.
'As we see for now, Hamas has an interest: First, to put pressure on the State of Israel through the international community in order to (have) an effect in the (ceasefire) negotiation process; and second, to collapse the new mechanism that we have established that is making sure that they are not involved in the aid delivery inside Gaza.'
International pressure continues to mount on Israel, including from the United States.
And on Monday, the foreign ministers of 25 Western nations slammed Israel for 'drip feeding' aid into the Gaza Strip. Israel's foreign ministry said it 'rejects' the statement, calling it 'disconnected from reality'.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Palestinians continue to die by Israeli fire as war in Gaza drags on
Palestinians continue to die by Israeli fire as war in Gaza drags on

7NEWS

time7 hours ago

  • 7NEWS

Palestinians continue to die by Israeli fire as war in Gaza drags on

Israeli strikes and gunfire has killed at least 46 Palestinians in the Gaza Strip, most of them among crowds seeking food. Many of the more than 30 people killed overnight were killed while seeking humanitarian aid, according to hospitals that treated dozens of wounded people. The Israeli military did not immediately comment on any of the strikes, but says it only targets militants and blames civilian deaths on Hamas because the group's militants operate in densely populated areas. The deaths came as the UK announced it would recognise a Palestinian state in September unless Israel agreed to a ceasefire in the Israel-Hamas war, following a similar declaration by France's president. Israel's foreign ministry said it rejected the British statement. The Shifa Hospital in Gaza City said it received 12 people who were killed on Tuesday night when Israeli forces opened fire towards crowds awaiting aid trucks coming from the Zikim crossing in northwestern Gaza. Thirteen others were killed in strikes in the Jabaliya refugee camp, and the northern towns of Beit Lahiya and Beit Hanoun, the hospital said. In the southern city of Khan Younis, the Nasser hospital said it received the bodies of 16 people who it says were killed on Tuesday evening while waiting for aid trucks close to the newly built Morag corridor, which separates Khan Younis from the southernmost city of Rafah. The hospital received another body for a man killed in a strike on a tent in Khan Younis, it said. The Awda hospital in the urban Nuseirat refugee camp said it received the bodies of four Palestinians who it says were killed on Wednesday by Israeli fire close to an aid distribution site run by the Gaza Humanitarian Foundation in the Netzarim corridor area, south of the Wadi Gaza. In addition, seven Palestinians, including a child, had died of malnutrition-related causes in the Gaza Strip in the past 24 hours, the territory's health ministry said on Wednesday. A total of 89 children have died of malnutrition since the war began in Gaza. The ministry said 65 Palestinian adults had also died of malnutrition-related causes across Gaza since late June, when it started counting deaths among adults. The current escalation in the region's conflict began when Hamas militants attacked southern Israel on October 7, 2023, and killed approximately 1200 people and abducted 251 others. They still hold 50 hostages, though Israel believes that more than half the remaining hostages are dead. Most of the rest were released in ceasefires or other deals. Israel's retaliatory offensive has killed more than 60,000 Palestinians, according to Gaza's health ministry.

BTN Newsbreak 31/07/2025
BTN Newsbreak 31/07/2025

ABC News

time9 hours ago

  • ABC News

BTN Newsbreak 31/07/2025

CANADA CALLS FOR PALESTINE STATE Canada has announced it plans to recognise a Palestinian state later this year, following in the footsteps of France and the UK earlier this month. That's Mark Carney announcing Canada's plans to recognise Palestinian statehood, which basically means it'll recognise Palestine as its own country. Right now, 147 countries in the UN already do that, but a handful don't, including Australia. In the last week, France, the UK, and now Canada have said they'll recognise Palestine as its own state, with hopes that the move will help bring peace to the war in Gaza. Israel's rejected their statements, saying it would be a reward to Hamas, but both Canada and the UK say that Palestinian recognition comes with a few rules. Australia hasn't officially recognised the state of Palestine, but yesterday they signed an agreement supporting a pathway towards it. Many world leaders, as well as the United Nations agree that the recognition of Palestine and Israel as two separate sates is the only way forward. EARTHQUAKE Today people are feeling a bit of relief after one of the strongest earthquakes ever recorded happened yesterday and caused surprisingly little damage. An 8.8 magnitude earthquake off of Russia's east coast yesterday sparked tsunami alerts across the Pacific including in Japan, China and the US. Tsunami threats have now been downgraded. The earthquake was the largest since 2011 and joint 6th largest to ever be recorded. Russian state media reported that the quake injured several people, but none of the injuries were serious. But experts are warning there may still be some aftershocks to come. DENTAL HYGIENE How often do you brush your teeth? Well, a new study has found that some Aussie kids aren't doing it as often as they should. Brushing twice a day helps keep the decay away, but is that what Aussie kids are really doing? See a big survey by the Australian Dental Association found 68% of Aussies kids brush twice a day. But 1 in 5 Aussie kids only brush once a day, and 76% never floss! And it's not just our brushing habits that have experts worried. While a lot of us know sugary drinks can lead to tooth decay, the study also found that 38% of kids drink fizzy drinks 2-5 times a week, and 27% of kids have fruit juice every day. Experts also say caring for our baby teeth is super important for lifelong oral heath, and building good habits early. SYDNEY TRAINS Now to Sydney, where Opal card readers have been turned off, allowing anyone to catch the train completely free. It's been a rough past year for Sydney trains, after months of delays, industrial action and cancelled services, they've recorded their worst ever performance, with nearly 1 in 5 train services running late, and some weeks, only about half of them were on time. But when asked if offering free trains for a couple days made up for the rail disruptions, most commuters agreed -- not really. Train travel will be free until 6am this Saturday, and Transport NSW is expected to lose about 6 million dollars in revenue. But if you're a Sydney bus, ferry, or light rail catcher, be warned, you've still got to pay for your ticket.

ASX Health Quarterly Wrap: Control Bionics makes 15pc sales revenue jump
ASX Health Quarterly Wrap: Control Bionics makes 15pc sales revenue jump

News.com.au

time10 hours ago

  • News.com.au

ASX Health Quarterly Wrap: Control Bionics makes 15pc sales revenue jump

As July draws to a close, today marks the official end of the June quarterly reporting period under ASX Listing Rules. These updates provide investors with a valuable snapshot of business momentum and future prospects with investors in healthcare watching signs of revenue growth, cash burn and future strategic direction. The June results are particularly pertinent as the last quarter of the financial year in Australia, providing an overview of the full year for many companies. Control Bionics (ASX:CBL) Control Bionics delivered a record year, with unaudited sales revenue rising 15% to more than $6 million and total revenue exceeding $7m in FY25. The company also reported an 8% lift in cash receipts, reaching $5.7m. During the quarter Control Bionics officially launched its NeuroNode Only sales model in the US following issuance of US Medicare reimbursement code E2513 under the Healthcare Common Procedure Coding System (HCPCS), locking in a rate of US$4300 (A$6600) per device. NeuroNode is a wearable, watch-like, wireless non-invasive electromyography (EMG) or spatial sensor device to assist people with physical disabilities perform everyday functions. Notably, this includes sufferers of cerebral palsy or motor neurone disease. Control Bionics said the US HCPCS reimbursement code laid the foundation for continued growth in the US, its largest addressable market. Discussions with multiple potential distribution partners in the US are well advanced. Control Bionics' Neuro Elite Athletics program NeuroBounce continues to gain commercial traction, diversifying its EMG technology into the sports performance market. Control Bionics has launched NeuroBounce in Australia with all five athletes in the initial four-week program improving their vertical jump height, with one recording an increase of 14 centimetres. Meanwhile, the company's NeuroNode device continues to gain traction in global markets. Following adoption within the UK's National Health Service (NHS), Control Bionics is now in active partnership discussions in both Europe and the US as it builds out its distribution-only strategy. In its NeuroStrip product line, Control Bionics has begun collecting EMG-labelled data from athletes and rehabilitation facilities with its development team now assessing opportunities to incorporate AI solutions to automate elements of the system. NeuroStrip hardware is now in use in both Australia and the US, with clinical evaluations underway across several areas. With growing international interest, expanding product lines, and a clear focus on commercialisation, Control Bionics said it had entered FY26 with strong momentum and multiple catalysts for further growth. Alterity Therapeutics (ASX:ATH) CEO and managing director Dr David Stamler said US Food and Drug Administration (FDA) fast track designation for ATH434 in multiple system atrophy (MSA) was the highlight of the recent quarter that also featured additional positive clinical data from its Phase 2 double-blind trial. "Receiving fast track designation alongside the orphan drug designation we have already received underscores the promise of this potentially disease-modifying therapy to address the urgent needs of individuals with MSA," he said. "In addition, we presented additional efficacy data from the ATH434-201 double-blind trial at prominent medical meetings, including slowing of disease progression on the Unified MSA Rating Scale or UMSARS, improvement in key symptoms of MSA, and preserved activity in the outpatient setting." Following quarter end Alterity this week announced positive results from its ATH434-202 open-label phase II clinical trial, in which ATH434 demonstrated a clinical benefit on the UMSARS and global assessments of neurological symptoms. Neuroimaging biomarkers showed target engagement and slowed brain atrophy in a manner consistent with the double-blind study findings with ATH434 continuing to demonstrate a favourable safety profile. "These data reinforce our confidence in the MSA program as we prepare for interactions with the US FDA," Stamler said. Alterity's cash position on June 30 was $40.66m, with operating cash outflows for the quarter of $2.35m. Neurotech International (ASX:NTI) Positive human PK study results for NTI164 released in June following preclinical toxicology results in May Data from Rett Syndrome program presented at the International Rett syndrome Foundation (IRSF) Annual Scientific Meeting Neurotech initiated formal engagement with US FDA in preparation for lodging an investigational new drug (IND) application in FY26 Neurotech's June quarter was marked by important clinical progress, growing international recognition, and further regulatory engagement for its lead investigational therapy NTI164, a proprietary CBDA-rich cannabinoid formulation being developed for paediatric neurological and inflammatory brain disorders. The company completed its first-in-human pharmacokinetic (PK) study. Conducted in healthy adult volunteers, the study confirmed that NTI164 is rapidly and predictably absorbed, with CBDA reaching peak plasma levels within 2–4 hours and emerging as the dominant circulating cannabinoid. Neurotech said the results validated NTI164's systemic stability, safety, and potential suitability for paediatric use. The PK study builds on preclinical toxicology results released in May, which demonstrated excellent tolerability in rats and dogs under GLP conditions. Neurotech also presented data from its Rett syndrome program at the International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting in Boston. Following the quarter, Neurotech announced that results from its phase I/II open-label clinical trial in Rett syndrome had been published in the Journal of Paediatrics and Child Health, a peer-reviewed scientific journal. Neurotech continued to progress its dual regulatory pathway strategy in Australia and the US during the quarter. In Australia, the company is moving toward potential product registration with the therapeutic Goods Administration (TGA) and is exploring expedited approval options to support timely market entry. The company has initiated formal engagement with the FDA in preparation for lodging an investigational new drug (IND) application in FY26. In June, Neurotech appointed leading US clinician Dr Bonni Goldstein as chief medical advisor USA, who has more than 25 years of clinical experience, including 17 years specialising in cannabinoid-based medicine. Goldstein is internationally recognised as a pioneer in paediatric cannabinoid therapy and brings key expertise as NTI164 progresses its development pathway. Also in June, CEO Dr Anthony Filippis attended the BIO International Convention in Boston as Neurotech continues to elevate its global profile and explore partnering and funding opportunities. Neurotech placed its wholly owned subsidiaries AAT Medical Ltd and AAT Research Ltd, responsible for the Mente neurofeedback device, into voluntary liquidation. The move reflects the company's focus on advancing NTI164. Operating cash outflows for the quarter were $2.6m, primarily driven by R&D expenditure supporting its FDA IND and TGA submissions, as well as clinical trial extension costs. Neurotech ended the period with $3m in cash and expects reduced outflows in Q1 FY26. A ~$3m R&D tax refund is anticipated in Q1 or early Q2 FY26 to further bolster cash reserves.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store